Rodnan Gp
Impact in
-
- Systemic Sclerosis and Related Diseases
- Dermatology top 5%
- Dermatologic Treatments and Research
- Skin Diseases and Diabetes
Papers in
-
- Systemic Sclerosis and Related Diseases 8
- Autoimmune Bullous Skin Diseases 1
-
- Skin Diseases and Diabetes 2
- Dermatologic Treatments and Research 1
- Co-authors
- Medsger Ta (3 shared papers)Anthony G. DiBartolomeo (1 shared paper)Alan Winkelstein (1 shared paper)T L Whiteside (1 shared paper)Hirohito M. Kondo (1 shared paper)B. S. Rabin (1 shared paper)Nirmala SundarRaj (1 shared paper)Ian L. Freeman (1 shared paper)
- Journals
- PubMed (9 papers)
In The Last Decade
Rodnan Gp
9 papers receiving 317 citations
Peers
Comparison fields: 5 of 41
- Pathology and Forensic Medicine 265
- Dermatology 121
- Rheumatology 134
- Epidemiology 126
- Immunology 50
Countries citing papers authored by Rodnan Gp
This map shows the geographic impact of Rodnan Gp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodnan Gp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodnan Gp more than expected).
Fields of papers citing papers by Rodnan Gp
This network shows the impact of papers produced by Rodnan Gp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodnan Gp. The network helps show where Rodnan Gp may publish in the future.
Co-authors
The 8 scholars most cited alongside Rodnan Gp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Bleomycin-induced scleroderma. | 1981 | 96 |
| 2 | The natural history of progressive systemic sclerosis (diffuse scleroderma). | 1963 | 69 |
| 3 | Proceedings: Eosinophilic fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome. | 1976 | 61 |
| 4 | The rheumatic manifestaions of progressive systemic sclerosis (scleroderma). | 1968 | 55 |
| 5 | HLA-DR antigens in progressive systemic sclerosis (scleroderma). | 1983 | 28 |
| 6 | When is scleroderma not scleroderma? The differential diagnosis of progressive systemic sclerosis. | 1981 | 26 |
| 7 | Stimulation of lymphocyte reactivity by a low molecular weight cutaneous antigen in patients with progressive systemic sclerosis (scleroderma). | 1979 | 14 |
| 8 | Surface proteins of scleroderma fibroblasts in culture. | 1984 | 9 |
| 9 | D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects. | 1983 | 9 |
About Rodnan Gp
Rodnan Gp is a scholar working on Pathology and Forensic Medicine, Dermatology, Rheumatology, Cell Biology and Genetics, having authored 9 papers that have together received 367 indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (8 papers), Dermatological and Skeletal Disorders (2 papers), Skin Diseases and Diabetes (2 papers), Skin and Cellular Biology Research (2 papers), Dermatologic Treatments and Research (1 paper), Autoimmune Bullous Skin Diseases (1 paper), Urticaria and Related Conditions (1 paper) and Celiac Disease Research and Management (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (265 citations), Dermatology (121 citations), Rheumatology (134 citations), Epidemiology (126 citations) and Immunology (50 citations). Frequent co-authors include Medsger Ta, Anthony G. DiBartolomeo, Alan Winkelstein, T L Whiteside, Hirohito M. Kondo, B. S. Rabin, Nirmala SundarRaj and Ian L. Freeman. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.